Literature DB >> 21664508

Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials.

Gilda Piaggio1, Nathalie Kapp, Helena von Hertzen.   

Abstract

BACKGROUND: Levonorgestrel is an effective method for emergency contraception (EC) and is used worldwide. Consistent with its mechanism of action in delaying ovulation, the earlier it is administered within 72 h of an unprotected act of intercourse, the more effective it is. There is uncertainty, however, about its effectiveness after 72 h. This analysis explores the effect of 24-h intervals of delay in levonorgestrel administration on pregnancy rates when used until 120 h of an unprotected act of intercourse. STUDY
DESIGN: Data were analyzed from 6794 women participating in four World Health Organization randomized trials and receiving 1.5 mg of levonorgestrel for EC in a single dose or split into two doses 12 h apart, within 48, 72 or 120 h of an act of unprotected intercourse. The pregnancy rates among women in successive days after an unprotected act of intercourse and odds ratios of pregnancy were calculated using logistic regression with the first day as the reference.
RESULTS: For the four trials combined, odds ratios for pregnancy in the second, third and fourth day with respect to the first day were not significantly different from 1 at the 5% level of significance. On the fifth day, the odds ratio of pregnancy compared to the first day was almost 6.
CONCLUSIONS: Levonorgestrel for EC should be administered as soon as possible after unprotected intercourse. Delaying levonorgestrel administration until the fifth day after unprotected intercourse increases the risk of pregnancy over five times compared with administration within 24 h. It is uncertain whether levonorgestrel administration on the fifth day still offers some protection against unwanted pregnancy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664508     DOI: 10.1016/j.contraception.2010.11.010

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

1.  Results from pooled Phase III studies of ulipristal acetate for emergency contraception.

Authors:  Caroline Moreau; James Trussell
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

2.  Hormonal contraception--what kind, when, and for whom?

Authors:  Inka Wiegratz; Christian J Thaler
Journal:  Dtsch Arztebl Int       Date:  2011-07-18       Impact factor: 5.594

Review 3.  Emergency contraception review: evidence-based recommendations for clinicians.

Authors:  Kelly Cleland; Elizabeth G Raymond; Elizabeth Westley; James Trussell
Journal:  Clin Obstet Gynecol       Date:  2014-12       Impact factor: 2.190

4.  Video counseling about emergency contraception: an observational study.

Authors:  Jessica N Sanders; Linh A Moran; Madeline Mullholand; Erica Torres; David K Turok
Journal:  Contraception       Date:  2019-03-23       Impact factor: 3.375

5.  Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial.

Authors:  Alison B Edelman; Jon D Hennebold; Kise Bond; Jeong Y Lim; Ganesh Cherala; David F Archer; Jeffrey T Jensen
Journal:  Obstet Gynecol       Date:  2022-06-07       Impact factor: 7.623

6.  Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing.

Authors:  Alison B Edelman; Ganesh Cherala; Steven W Blue; David W Erikson; Jeffrey T Jensen
Journal:  Contraception       Date:  2016-03-18       Impact factor: 3.375

Review 7.  Does levonorgestrel emergency contraceptive have a post-fertilization effect? A review of its mechanism of action.

Authors:  Rebecca Peck; Walter Rella; Julio Tudela; Justo Aznar; Bruno Mozzanega
Journal:  Linacre Q       Date:  2016-02

Review 8.  Emerging options for emergency contraception.

Authors:  Atsuko Koyama; Laura Hagopian; Judith Linden
Journal:  Clin Med Insights Reprod Health       Date:  2013-02-18

Review 9.  Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects.

Authors:  Sally Rafie; Rebecca H Stone; Tracey A Wilkinson; Laura M Borgelt; Shareen Y El-Ibiary; Denise Ragland
Journal:  Integr Pharm Res Pract       Date:  2017-03-23

10.  A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.

Authors:  Mario P R Festin; Luis Bahamondes; Thi My Huong Nguyen; Ndema Habib; Manopchai Thamkhantho; Kuldip Singh; Arundhati Gosavi; Gyorgy Bartfai; Tamas Bito; M Valeria Bahamondes; Nathalie Kapp
Journal:  Hum Reprod       Date:  2016-01-31       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.